Identification of a tumor suppressor network in T-cell leukemia

References

• Karrman K, Johansson B. Pediatric T-cell acute lymphoblastic leukemia. Genes Chromosomes Cancer. 2016;56(2):89–116.
   PubMed Web of Science ®Google Scholar
• Armstrong SA, Look AT. Molecular genetics of acute lymphoblastic leukemia. J Clin Oncol. 2005;23:6306–6315.
   PubMed Web of Science ®Google Scholar
• Graux C, Cools J, Michaux L, et al. Cytogenetics and molecular genetics of T-cell acute lymphoblastic leukemia: from thymocyte to lymphoblast. Leukemia. 2006;20:1496–1510.
   PubMed Web of Science ®Google Scholar
• Van Vlierberghe P, Ferrando A. The molecular basis of T cell acute lymphoblastic leukemia. J Clin Invest. 2012;122:3398–3406.
   PubMed Web of Science ®Google Scholar
• Yui MA, Rothenberg EV. Developmental gene networks: a triathlon on the course to T cell identity. Nat Rev Immunol. 2014;14:529–545.
   PubMed Web of Science ®Google Scholar
• Ferrando AA, Neuberg DS, Staunton J, et al. Gene expression signatures define novel oncogenic pathways in T cell acute lymphoblastic leukemia. Cancer Cell. 2002;1:75–87.
   PubMed Web of Science ®Google Scholar
• O'Neil J, Grim J, Strack P, et al. FBW7 mutations in leukemic cells mediate NOTCH pathway activation and resistance to gamma-secretase inhibitors. J Exp Med. 2007;204:1813–1824.
   PubMed Web of Science ®Google Scholar
• Van Vlierberghe P, van Grotel M, Tchinda J, et al. The recurrent SET-NUP214 fusion as a new HOXA activation mechanism in pediatric T-cell acute lymphoblastic leukemia. Blood. 2008;111:4668–4680.
   PubMed Web of Science ®Google Scholar
• Kleppe M, Lahortiga I, El Chaar T, et al. Deletion of the protein tyrosine phosphatase gene PTPN2 in T-cell acute lymphoblastic leukemia. Nat Genet. 2010;42:530–535.
   PubMed Web of Science ®Google Scholar
• Nagel S, Meyer C, Quentmeier H, et al. MEF2C is activated by multiple mechanisms in a subset of T-acute lymphoblastic leukemia cell lines. Leukemia. 2008;22:600–607.
   PubMed Web of Science ®Google Scholar
• Nagel S, Venturini L, Meyer C, et al. Multiple mechanisms induce ectopic expression of LYL1 in subsets of T-ALL cell lines. Leuk Res. 2010;34:521–528.
   PubMed Web of Science ®Google Scholar
• Nagel S, Venturini L, Przybylski GK, et al. Activation of paired-homeobox gene PITX1 by del(5)(q31) in T-cell acute lymphoblastic leukemia. Leuk Lymphoma. 2011;52:1348–1359.
   PubMed Web of Science ®Google Scholar
• Hnisz D, Weintraub AS, Day DS, et al. Activation of proto-oncogenes by disruption of chromosome neighborhoods. Science. 2016;351:1454–1458.
   PubMed Web of Science ®Google Scholar
• Clappier E, Cuccuini W, Kalota A, et al. The C-MYB locus is involved in chromosomal translocation and genomic duplications in human T-cell acute leukemia (T-ALL), the translocation defining a new T-ALL subtype in very young children. Blood. 2007;110:1251–1261.
   PubMed Web of Science ®Google Scholar
• Nagel S, Ehrentraut S, Meyer C, et al. Repressed BMP signaling reactivates NKL homeobox gene MSX1 in a T-ALL subset. Leuk Lymphoma. 2015;56:480–491.
   PubMed Web of Science ®Google Scholar
• Ellisen LW, Bird J, West DC, et al. TAN-1, the human homolog of the Drosophila notch gene, is broken by chromosomal translocations in T lymphoblastic neoplasms. Cell. 1991;66:649–661.
   PubMed Web of Science ®Google Scholar
• Weng AP, Ferrando AA, Lee W, et al. Activating mutations of NOTCH1 in human T cell acute lymphoblastic leukemia. Science. 2004;306:269–271.
   PubMed Web of Science ®Google Scholar
• Hodson DJ, Janas ML, Galloway A, et al. Deletion of the RNA-binding proteins ZFP36L1 and ZFP36L2 leads to perturbed thymic development and T lymphoblastic leukemia. Nat Immunol. 2010;11:717–724.
   PubMed Web of Science ®Google Scholar
• Nehls M, Kyewski B, Messerle M, et al. Two genetically separable steps in the differentiation of thymic epithelium. Science. 1996;272:886–889.
   PubMed Web of Science ®Google Scholar
• Bajoghli B, Aghaallaei N, Hess I, et al. Evolution of genetic networks underlying the emergence of thymopoiesis in vertebrates. Cell. 2009;138:186–197.
   PubMed Web of Science ®Google Scholar
• Swann JB, Weyn A, Nagakubo D, et al. Conversion of the thymus into a bipotent lymphoid organ by replacement of FOXN1 with its paralog, FOXN4. Cell Rep. 2014;8:1184–1197.
   PubMed Web of Science ®Google Scholar
• Suzuki S, Nagel S, Schneider B, et al. A second NOTCH1 chromosome rearrangement: t(9;14)(q34.3;q11.2) in T-cell neoplasia. Leukemia. 2009;23:1003–1006.
   PubMed Web of Science ®Google Scholar
• MacLeod RA, Nagel S, Kaufmann M, et al. Activation of HOX11L2 by juxtaposition with 3'-BCL11B in an acute lymphoblastic leukemia cell line (HPB-ALL) with t(5;14)(q35;q32.2). Genes Chromosomes Cancer. 2003;37:84–91.
   PubMed Web of Science ®Google Scholar
• Nagel S, Kaufmann M, Drexler HG, et al. The cardiac homeobox gene NKX2-5 is deregulated by juxtaposition with BCL11B in pediatric T-ALL cell lines via a novel t(5;14)(q35.1;q32.2). Cancer Res. 2003;63:5329–5334.
   PubMed Web of Science ®Google Scholar
• Drexler HG, Guide to leukemia-lymphoma cell lines. 2nd ed. Braunschweig: DSMZ; 2010.
   Google Scholar
• Nagel S, Venturini L, Meyer C, et al. Transcriptional deregulation of oncogenic myocyte enhancer factor 2C in T-cell acute lymphoblastic leukemia. Leuk Lymphoma. 2011;52:290–297.
   PubMed Web of Science ®Google Scholar
• Homminga I, Pieters R, Langerak AW, et al. Integrated transcript and genome analyses reveal NKX2-1 and MEF2C as potential oncogenes in T cell acute lymphoblastic leukemia. Cancer Cell. 2011;19:484–497.
   PubMed Web of Science ®Google Scholar
• Huang da W, Sherman BT, Lempicki RA. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc. 2009;4:44–57.
   PubMed Web of Science ®Google Scholar
• Berger R, Le Coniat M, Vecchione D, et al. Cytogenetic studies of 44 T-cell acute lymphoblastic leukemias. Cancer Genet Cytogenet. 1990;44:69–75.
   PubMedGoogle Scholar
• Bernard OA, Busson-LeConiat M, Ballerini P, et al. A new recurrent and specific cryptic translocation, t(5;14)(q35;q32), is associated with expression of the Hox11L2 gene in T acute lymphoblastic leukemia. Leukemia. 2001;15:1495–1504.
   PubMed Web of Science ®Google Scholar
• Martínez-Ramírez A, Urioste M, Contra T, et al. Fluorescence in situ hybridization study of TEL/AML1 fusion and other abnormalities involving TEL and AML1 genes. Correlation with cytogenetic findings and prognostic value in children with acute lymphocytic leukemia. Haematologica. 2001;86:1245–1253.
   PubMed Web of Science ®Google Scholar
• Rowley JD, Reshmi S, Carlson K, et al. Spectral karyotype analysis of T-cell acute leukemia. Blood. 1999;93:2038–2042.
   PubMed Web of Science ®Google Scholar
• van Grotel M, Meijerink JP, Beverloo HB, et al. The outcome of molecular-cytogenetic subgroups in pediatric T-cell acute lymphoblastic leukemia: a retrospective study of patients treated according to DCOG or COALL protocols. Haematologica. 2006;91:1212–1221.
   PubMed Web of Science ®Google Scholar
• Uddin S, Bhat AA, Krishnankutty R, et al. Involvement of F-BOX proteins in progression and development of human malignancies. Semin Cancer Biol. 2016;36:18–32.
   PubMed Web of Science ®Google Scholar
• Hannah J, Zhou P. Distinct and overlapping functions of the cullin E3 ligase scaffolding proteins CUL4A and CUL4B. Gene. 2015;573:33–45.
   PubMed Web of Science ®Google Scholar
• Nagel S, Schneider B, Rosenwald A, et al. t(4;8)(q27;q24) in Hodgkin lymphoma cells targets phosphodiesterase PDE5A and homeobox gene ZHX2. Genes Chromosomes Cancer. 2011;50:996–1009.
   PubMed Web of Science ®Google Scholar
• Nagel S, Schneider B, Meyer C, et al. Transcriptional deregulation of homeobox gene ZHX2 in Hodgkin lymphoma. Leuk Res. 2012;36:646–655.
   PubMed Web of Science ®Google Scholar
• Edelbrock MA, Kaliyaperumal S, Williams KJ. Structural, molecular and cellular functions of MSH2 and MSH6 during DNA mismatch repair, damage signaling and other noncanonical activities. Mutat Res. 2013;743–744:53–66.
   PubMed Web of Science ®Google Scholar
• Muro Y, Sugiura K, Mimori T, et al. DNA mismatch repair enzymes: genetic defects and autoimmunity. Clin Chim Acta. 2015;442:102–109.
   PubMed Web of Science ®Google Scholar
• Duan S, Cermak L, Pagan JK, et al. FBXO11 targets BCL6 for degradation and is inactivated in diffuse large B-cell lymphomas. Nature. 2012;481:90–93.
   PubMed Web of Science ®Google Scholar
• Dai H, Ehrentraut S, Nagel S, et al. Genomic landscape of primary mediastinal B-Cell lymphoma cell lines. PLoS One. 2015;10:e0139663.
   PubMed Web of Science ®Google Scholar
• Rossi M, Duan S, Jeong YT, et al. Regulation of the CRL4(Cdt2) ubiquitin ligase and cell-cycle exit by the SCF(Fbxo11) ubiquitin ligase. Mol Cell. 2013;49:1159–1166.
   PubMed Web of Science ®Google Scholar
• Abbas T, Mueller AC, Shibata E, et al. CRL1-FBXO11 promotes Cdt2 ubiquitylation and degradation and regulates Pr-Set7/Set8-mediated cellular migration. Mol Cell. 2013;49:1147–1158.
   PubMed Web of Science ®Google Scholar
• Randle SJ, Laman H. F-box protein interactions with the hallmark pathways in cancer. Semin Cancer Biol. 2016;36:3–17.
   PubMed Web of Science ®Google Scholar
• Fielenbach N, Guardavaccaro D, Neubert K, et al. DRE-1: an evolutionarily conserved F box protein that regulates C. elegans developmental age. Dev Cell. 2007;12:443–455.
   PubMed Web of Science ®Google Scholar
• Horn M, Geisen C, Cermak L, et al. DRE-1/FBXO11-dependent degradation of BLMP-1/BLIMP-1 governs C. elegans developmental timing and maturation. Dev Cell. 2014;28:697–710.
   PubMed Web of Science ®Google Scholar
• Hannenhalli S, Kaestner KH. The evolution of Fox genes and their role in development and disease. Nat Rev Genet. 2009;10:233–240.
   PubMed Web of Science ®Google Scholar
• Jackson BC, Carpenter C, Nebert DW, et al. Update of human and mouse forkhead box (FOX) gene families. Hum Genomics. 2010;4:345–352.
   PubMedGoogle Scholar
• Nakagawa S, Gisselbrecht SS, Rogers JM, et al. DNA-binding specificity changes in the evolution of forkhead transcription factors. Proc Natl Acad Sci USA. 2013;110:12349–12354.
   PubMed Web of Science ®Google Scholar
• Tribioli C, Robledo RF, Lufkin T. The murine fork head gene Foxn2 is expressed in craniofacial, limb, CNS and somitic tissues during embryogenesis. Mech Dev. 2002;118:161–163.
   PubMed Web of Science ®Google Scholar
• Schuff M, Rössner A, Donow C, et al. Temporal and spatial expression patterns of FoxN genes in Xenopus laevis embryos. Int J Dev Biol. 2006;50:429–434.
   PubMed Web of Science ®Google Scholar
• Samaan G, Yugo D, Rajagopalan S, et al. Foxn3 is essential for craniofacial development in mice and a putative candidate involved in human congenital craniofacial defects. Biochem Biophys Res Commun. 2010;400:60–65.
   PubMed Web of Science ®Google Scholar
• Robertson E, Perry C, Doherty R, et al. Transcriptomic profiling of Forkhead box transcription factors in adult glioblastoma multiforme. Cancer Genomics Proteomics. 2015;12:103–112.
   PubMed Web of Science ®Google Scholar
• Zhang J, Ding L, Holmfeldt L, et al. The genetic basis of early T-cell precursor acute lymphoblastic leukaemia. Nature. 2012;481:157–163.
   PubMed Web of Science ®Google Scholar
• Liu Y, Ma D, Ji C. Zinc fingers and homeoboxes family in human diseases. Cancer Gene Ther. 2015;22:223–226.
   PubMed Web of Science ®Google Scholar
• Nagel S, Ehrentraut S, Meyer C, et al. Aberrantly expressed OTX homeobox genes deregulate B-cell differentiation in Hodgkin lymphoma. PLoS One. 2015;10:e0138416.
   PubMed Web of Science ®Google Scholar
• Li B, Jia N, Waning DL, et al. Cul4A is required for hematopoietic stem-cell engraftment and self-renewal. Blood. 2007;110:2704–2707.
   PubMed Web of Science ®Google Scholar
• Kitagawa K, Kitagawa M. The SCF ubiquitin ligases involved in hematopoietic lineage. Curr Drug Targets. 2012;13:1641–1648.
   PubMed Web of Science ®Google Scholar
• Han J, Zhang H, Zhang H, et al. A Cul4 E3 ubiquitin ligase regulates histone hand-off during nucleosome assembly. Cell. 2013;155:817–829.
   PubMed Web of Science ®Google Scholar
• Gracheva E, Chitale S, Wilhelm T, et al. ZRF1 mediates remodeling of E3 ligases at DNA lesion sites during nucleotide excision repair. J Cell Biol. 2016;213:185–200.
   PubMed Web of Science ®Google Scholar
• Choi SH, Wright JB, Gerber SA, et al. Myc protein is stabilized by suppression of a novel E3 ligase complex in cancer cells. Genes Dev. 2010;24:1236–1241.
   PubMed Web of Science ®Google Scholar
• Kim K, Lee B, Kim J, et al. Linker Histone H1.2 cooperates with Cul4A and PAF1 to drive H4K31 ubiquitylation-mediated transactivation. Cell Rep. 2013;5:1690–1703.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Morrone G, Zhang J, et al. CUL-4A stimulates ubiquitylation and degradation of the HOXA9 homeodomain protein. Embo J. 2003;22:6057–6067.
   PubMed Web of Science ®Google Scholar
• Lee J, Zhou P. Pathogenic role of the CRL4 ubiquitin ligase in human disease. Front Oncol. 2012;2:21.
   PubMedGoogle Scholar
• Lee J, Shieh JH, Zhang J, et al. Improved ex vivo expansion of adult hematopoietic stem cells by overcoming CUL4-mediated degradation of HOXB4. Blood. 2013;121:4082–4089.
   PubMed Web of Science ®Google Scholar
• Kanei-Ishii C, Nomura T, Egoh A, et al. Fbxw5 suppresses nuclear c-Myb activity via DDB1-Cul4-Rbx1 ligase-mediated sumoylation. Biochem Biophys Res Commun. 2012;426:59–64.
   PubMed Web of Science ®Google Scholar
• Mao X, Lillington DM, Czepulkowski B, et al. A case of adult T-cell leukaemia/lymphoma characterized by multiplex-fluorescence in situ hybridization, comparative genomic hybridization, fluorescence in situ hybridization and cytogenetics. Br J Dermatol. 2001;145:117–122.
   PubMed Web of Science ®Google Scholar
• Palomero T, Odom DT, O'Neil J, et al. Transcriptional regulatory networks downstream of TAL1/SCL in T-cell acute lymphoblastic leukemia. Blood. 2006;108:986–992.
   PubMed Web of Science ®Google Scholar
• Lausen J, Pless O, Leonard F, et al. Targets of the Tal1 transcription factor in erythrocytes: E2 ubiquitin conjugase regulation by Tal1. J Biol Chem. 2010;285:5338–5346.
   PubMed Web of Science ®Google Scholar
• Vilimas T, Mascarenhas J, Palomero T, et al. Targeting the NF-kappaB signaling pathway in Notch1-induced T-cell leukemia. Nat Med. 2007;13:70–77.
   PubMed Web of Science ®Google Scholar
• Koyama D, Kikuchi J, Hiraoka N, et al. Proteasome inhibitors exert cytotoxicity and increase chemosensitivity via transcriptional repression of Notch1 in T-cell acute lymphoblastic leukemia. Leukemia. 2014;28:1216–1226.
   PubMed Web of Science ®Google Scholar
• Horton TM, Drachtman RA, Chen L, et al. A phase 2 study of bortezomib in combination with ifosfamide/vinorelbine in paediatric patients and young adults with refractory/recurrent Hodgkin lymphoma: a Children's Oncology Group study. Br J Haematol. 2015;170:118–122.
   PubMed Web of Science ®Google Scholar
• Ravi D, Beheshti A, Abermil N, et al. Proteasomal inhibition by Ixazomib induces CHK1 and MYC dependent cell death in T-cell and Hodgkin lymphoma. Cancer Res. 2016;76:3319–3331.
   PubMed Web of Science ®Google Scholar
• Balzarotti M, Brusamolino E, Angelucci E, et al. B-IGEV (bortezomib plus IGEV) versus IGEV before high-dose chemotherapy followed by autologous stem cell transplantation in relapsed or refractory Hodgkin lymphoma: a randomized, phase II trial of the Fondazione Italiana Linfomi (FIL). Leuk Lymphoma. 2016;57:2375–2381.
   PubMed Web of Science ®Google Scholar